Latest Research in Nanoparticle-Based Drug Delivery
28 research papers · 2026 median publication year
Top Research Topics in Nanoparticle-Based Drug Delivery
- Nanoplatforms for cancer theranostics — 7 papers
- Nanoparticle-Based Drug Delivery — 3 papers
- Supramolecular Self-Assembly in Materials — 2 papers
- Ferroptosis and cancer prognosis — 2 papers
- Cancer Research and Treatments — 2 papers
- Chemotherapy-induced cardiotoxicity and mitigation — 1 papers
- Ultrasound and Hyperthermia Applications — 1 papers
- Andrographolide Research and Applications — 1 papers
- Advanced Nanomaterials in Catalysis — 1 papers
- Cancer, Hypoxia, and Metabolism — 1 papers
Highest-Cited Papers
- Monitoring of Doxorubicin-Mediated Mitochondria–Lysosome Crosstalk by In Situ Raman Spectroscopy: The Molecular Mechanism during Apoptosis and Implications for Cardiotoxicity
- Pathogen‐Guided In Situ Secondary H‐Aggregate Assembly for Self‐Amplified Theranostic of Fusobacterium nucleatum ‐Infected Colorectal Cancer
- Ultrasound triggered microbubbles enhance the diagnosis and therapy of colorectal cancer
- Naphthalimide-based andrographolide nanoplatform suppresses ccRCC via targeting the HIF-2α/VEGF signaling axis
- A bladder microenvironment-adaptive ceria nanozyme hydrogel enables urea-responsive intravesical chemo-immunotherapy
- Application of iron oxide nanoparticles in leukaemia treatment in low and middle income countries: proof of concept
- Metformin-conjugated radiopaque nanogels with RF-triggered phase transition for programmable embolization and PD-L1 degradation
- A Covalent Brush‐on‐Brush Polymer Programs Ordered Intracellular Activation of a Mitochondria‐Disrupting Peptide
- Temporal remodeling of the post–irreversible electroporation stromal–immune barrier in pancreatic cancer via dual-targeted microspheres
- A Covalent Brush‐on‐Brush Polymer Programs Ordered Intracellular Activation of a Mitochondria‐Disrupting Peptide
- Biodegradable Polymeric Nanogels vs Polymer-Drug Conjugates: A Superior Drug Delivery Strategy Enabling Potentiated Cancer Treatment
- Functionalized Red Blood Cell Membrane Nanoplatform for Paclitaxel and Artesunate Induces Ferroptosis and Immunogenic Cell Death against Triple-Negative Breast Cancer
- Multifaceted In Silico and DFT-Based Analysis of 2-Aminosuccinic Acid on Ferroptosis-Related Targets
- Aptamer-conjugated curcumin nanomedicine: targeted drug delivery and theranostic innovations in cancer Immunotherapy
- Generation of GPC-3-targeted radicals for precise therapy of hepatocellular carcinoma
- Ultrasound‐Activated Nanoinhibitors Blocking the Chemo‐Immune Checkpoint to Overcome Chemotherapy‐Induced Immune Resistance
- Neutrophil-Inspired Programmable Bacteria for Pyroptosis-Driven Tumor Eradication
- Specific Adsorption of Tumor‐Affinity Proteins to Improve Tumor Accumulation for Targeted Imaging and Therapy
- Research Progress on Tumor Microenvironment-Responsive siRNA Nanocarriers: Design Strategies, Delivery Efficiency, and Future Perspectives
- Chlorogenic Acid in Antitumor Therapy: Multi-Pathway Mechanisms, Nanocarrier-Mediated Smart Delivery, and Synergistic Combinatorial Strategies